| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000044513 |
| Receipt No. | R000050833 |
| Scientific Title | A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold. |
| Date of disclosure of the study information | 2021/06/13 |
| Last modified on | 2021/10/29 (Ver. 2) |
| Basic information | ||
| Public title | A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold. | |
| Acronym | A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold. | |
| Scientific Title | A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold. | |
| Scientific Title:Acronym | A study for effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions in healthy adult female who are concerned about cold. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effects on body surface temperature and feeling of "Ninnikushoga" intake under cool conditions. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Area under the curve of body surface temperature |
| Key secondary outcomes | Body surface temperature
Autonomic function Subjective symptoms questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food (single ingestion) - washing out (a day or more) - intake of placebo (single ingestion) | |
| Interventions/Control_2 | Intake of placebo (single ingestion) - washing out (a day or more) - intake of test food (single ingestion) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | (1)Healthy females from 20 to 64 years of age
(2)Subjects who are aware of getting cold of fingers under air conditioner working (3)Subjects who live an ordered life (4)Subjects who drop body surface temperature under cool conditions on preliminary examination |
|||
| Key exclusion criteria | (1)Subjects who have been diagnosed underlying disease accompanied with angiopathy (e.g. arteriosclerosis obliterans, arteritis obliterans, collagen disease and diabetes, etc.)
(2)Subjects who constantly take medicines affecting the skin surface temperature(e.g. warfarin) (3)Subjects who eat food for specified health or health food affecting the skin surface temperature(e.g. healthy food including garlic or ginger) at least once a week (4)Subjects having food allergy (5)Subjects who are smokers or have smoked within the past 3 months (6)Subjects who have a scar affecting the skin surface temperature and autonomic function on fingers, palms, toes and insteps (7)Subjects who have worked shifts day and night or are planned to work shifts day and night from a month before obtaining the consent for this study to the date of the completion this study (8)Subjects who have gone abroad or are planned to go abroad from a month before obtaining the consent for this study to the date of the completion this study (9)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (10)Subjects who intend to become pregnant or lactating during the study (11)Subjects having a disease requiring treatment or taking medicines (12)Subjects having a history of serious diseases (13)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (14)Subjects who are not judged as healthy based on the results of clinical and physical examination on preliminary examination (15)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination |
|||
| Target sample size | 16 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kenkoukazoku Co., Ltd. | ||||||
| Division name | None | ||||||
| Zip code | 892-0848 | ||||||
| Address | 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN | ||||||
| TEL | 099-223-5211 | ||||||
| yasushi.nakasone@kenkoukazoku.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | EP Mediate Co., Ltd. | ||||||
| Division name | Development Business Headquarters, TTC Center, Trial Planning Department | ||||||
| Zip code | 162-0822 | ||||||
| Address | Tsuruya Bldg.,2-23, Shimomiyabicho, Shinjuku-ku, Tokyo | ||||||
| TEL | 03-5657-4983 | ||||||
| Homepage URL | |||||||
| bansho189@eps.co.jp | |||||||
| Sponsor | |
| Institute | EP Mediate Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kenkoukazoku Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Station Clinic Research Ethics Committee |
| Address | 3-12-8, Takaban, Meguroku, Tokyo |
| Tel | 080-2290-2544 |
| makabe295@eps.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050833 |